Compounds of structural formula (I): and pharmaceutically acceptable salts thereof; as defined herein, are described for use in the prevention and/or treatment of HCV infections. Novel compounds of the formula (I) and pharmaceutical formulations containing them are also described.
申请公布号
WO2010084115(A2)
申请公布日期
2010.07.29
申请号
WO2010EP50578
申请日期
2010.01.19
申请人
ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A.;SUMMA, VINCENZO;DI FRANCESCO, MARIA EMILIA;POMPEI, MARCO
发明人
SUMMA, VINCENZO;DI FRANCESCO, MARIA EMILIA;POMPEI, MARCO
